{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:02:06Z","timestamp":1791889326724,"version":"4.3.4"},"reference-count":90,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1210\/er.2001-5002","type":"journal-article","created":{"date-parts":[[2002,8,30]],"date-time":"2002-08-30T17:22:48Z","timestamp":1030728168000},"page":"529-539","source":"Crossref","is-referenced-by-count":289,"title":["V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women"],"prefix":"10.1210","volume":"23","author":[{"given":"George","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Zytaruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Cranney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The osteoporosis methodology group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Osteoporosis Research Advisory Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2019041122262581700_R1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1532-5415.1997.tb00941.x","article-title":"The economic cost of hip fractures in community-dwelling older adults: a prospective study.","volume":"45","author":"Brainsky","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"2019041122262581700_R2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","article-title":"Estrogen replacement therapy and fractures in older women.","volume":"122","author":"Cauley","year":"1995","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-116-9-716","article-title":"Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women.","volume":"116","author":"Kiel","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01623654","article-title":"Fracture protection provided by long-term estrogen treatment.","volume":"5","author":"Maxim","year":"1995","journal-title":"Osteoporosis Int"},{"key":"2019041122262581700_R5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-113-2-95","article-title":"Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study.","volume":"113","author":"Naessen","year":"1990","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement study (HERS) Research Group.","volume":"280","author":"Hully","year":"1998","journal-title":"JAMA"},{"key":"2019041122262581700_R7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/13697139809085526","article-title":"A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.","volume":"1","author":"O\u2019Connell","year":"1998","journal-title":"Climacteric"},{"key":"2019041122262581700_R8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen.","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews.","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"2019041122262581700_R10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of randomized trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"2019041122262581700_R11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis.","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"2019041122262581700_R12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(96)00384-5","article-title":"Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.","volume":"20","author":"Abrahamsen","year":"1997","journal-title":"Bone"},{"key":"2019041122262581700_R13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0169-6009(89)90064-0","article-title":"Transdermal estradiol in the treatment of postmenopausal bone loss.","volume":"7","author":"Adami","year":"1989","journal-title":"Bone Miner"},{"key":"2019041122262581700_R14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF03349583","article-title":"Calcitonin and estrogens.","volume":"13","author":"Agnusdei","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"2019041122262581700_R15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF01626609","article-title":"Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug Ipriflavone.","volume":"5","author":"Agnusdei","year":"1995","journal-title":"Osteoporosis Int"},{"key":"2019041122262581700_R16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-120-2-199401150-00001","article-title":"Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss.","volume":"120","author":"Aloia","year":"1994","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-5122(91)90237-K","article-title":"Neuroendocrine and clinical effects of transdermal 17\u03b2-estradiol in postmenopausal women.","volume":"13","author":"Cagnacci","year":"1991","journal-title":"Maturitas"},{"key":"2019041122262581700_R18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0028-2243(92)90058-7","article-title":"The effect of hormone replacement therapy on postmenopausal bone loss.","volume":"44","author":"Castelo-Branco","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041122262581700_R19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-5122(93)90057-O","article-title":"Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry.","volume":"16","author":"Castelo-Branco","year":"1993","journal-title":"Maturitas"},{"key":"2019041122262581700_R20","first-page":"911","article-title":"Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.","volume":"106","author":"Cheng","year":"1993","journal-title":"Chin Med J"},{"key":"2019041122262581700_R21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2362.1981.tb02121.x","article-title":"Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.","volume":"11","author":"Christiansen","year":"1981","journal-title":"Eur J Clin Invest"},{"key":"2019041122262581700_R22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF02409494","article-title":"Factors in response to treatment of early postmenopausal bone loss.","volume":"33","author":"Christiansen","year":"1981","journal-title":"Calcif Tissue Int"},{"key":"2019041122262581700_R23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9378(82)90176-4","article-title":"Dose-response evaluation of cyclic estrogen\/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.","volume":"144","author":"Christensen","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122262581700_R24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem-71-4-836","article-title":"17 \u03b2-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.","volume":"71","author":"Christiansen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122262581700_R25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02556338","article-title":"Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1\u03b1-hydroxylase reserve in postmenopausal osteoporosis.","volume":"42","author":"Civitelli","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"2019041122262581700_R26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/0002-9378(95)90631-2","article-title":"Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.","volume":"173","author":"Doren","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122262581700_R27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9378(92)91653-R","article-title":"Low-dosage micronized 17\u03b2-estradiol prevents bone loss in postmenopausal women.","volume":"166","author":"Ettinger","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122262581700_R28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jbmr.5650100505","article-title":"Cyclical Clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy.","volume":"10","author":"Filipponi","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2019041122262581700_R29","first-page":"193","article-title":"Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen\/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.","volume":"54","author":"Finn Jensen","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122262581700_R30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(91)90538-9","article-title":"Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.","volume":"90","author":"Gallagher","year":"1991","journal-title":"Am J Med"},{"key":"2019041122262581700_R31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/09513599509160202","article-title":"Prospective evaluation of calcium and estrogen administration on bone mass and metabolism after ovariectomy.","volume":"9","author":"Gambacciani","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"2019041122262581700_R32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5122(97)00059-5","article-title":"Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.","volume":"28","author":"Gambacciani","year":"1997","journal-title":"Maturitas"},{"key":"2019041122262581700_R33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-97-5-699","article-title":"Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy.","volume":"97","author":"Genant","year":"1982","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R34","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab\/Osteoporosis Study Group.","volume":"157","author":"Genant","year":"1997","journal-title":"Arch Intern Med"},{"key":"2019041122262581700_R35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5122(91)90099-C","article-title":"Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis.","volume":"13","author":"Geusens","year":"1991","journal-title":"Maturitas"},{"key":"2019041122262581700_R36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.1997.12.4.624","article-title":"The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis.","volume":"12","author":"Gonnelli","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2019041122262581700_R37","author":"Greenspan","year":"1998"},{"key":"2019041122262581700_R38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/archinte.1991.00400100060010","article-title":"The effects of estrone (Ogen) on spinal bone density of postmenopausal women.","volume":"151","author":"Harris","year":"1991","journal-title":"Arch Intern Med"},{"key":"2019041122262581700_R39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5122(96)01098-5","article-title":"HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.","volume":"26","author":"Heikkinen","year":"1997","journal-title":"Maturitas"},{"key":"2019041122262581700_R40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02672513","article-title":"Monitoring estrogen replacement therapy and identifying rapid bone losers with an immunoassay for deoxypyridinoline.","volume":"8","author":"Hesley","year":"1998","journal-title":"Osteoporosis Int"},{"key":"2019041122262581700_R41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.2.6090.789","article-title":"Prospective trial of oestrogen and calcium in postmenopausal women.","volume":"2","author":"Horsman","year":"1977","journal-title":"Br Med J"},{"key":"2019041122262581700_R42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.","volume":"338","author":"Hosking","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041122262581700_R43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-5122(89)90025-X","article-title":"Calcitonin and lumbar bone mineral content during oestrogen-progestogen administration in post-menopausal women.","volume":"11","author":"Isaia","year":"1989","journal-title":"Maturitas"},{"key":"2019041122262581700_R44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF01623687","article-title":"Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.","volume":"7","author":"Komulainen","year":"1997","journal-title":"Osteoporosis Int"},{"key":"2019041122262581700_R45","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","article-title":"Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.","volume":"1","author":"Lindsay","year":"1976","journal-title":"Lancet"},{"key":"2019041122262581700_R46","first-page":"193","article-title":"Comparative effects of oestrogen and progestogen on bone loss in postmenopausal women.","volume":"54","author":"Lindsay","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"2019041122262581700_R47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.280.6225.1207","article-title":"Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.","volume":"280","author":"Lindsay","year":"1980","journal-title":"BMJ"},{"key":"2019041122262581700_R48","first-page":"759","article-title":"The minimum effective dose of estrogen for prevention of postmenopausal bone loss.","volume":"63","author":"Lindsay","year":"1984","journal-title":"Obstet Gynecol"},{"key":"2019041122262581700_R49","first-page":"290","article-title":"Estrogen treatment of patients with established postmenopausal osteoporosis.","volume":"76","author":"Lindsay","year":"1990","journal-title":"Obstet Gynecol"},{"key":"2019041122262581700_R50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0378-5122(95)00933-C","article-title":"Prevention of post-oophorectomy bone loss with Tibolone.","volume":"22","author":"Lyritis","year":"1995","journal-title":"Maturitas"},{"key":"2019041122262581700_R51","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(88)91712-6","article-title":"Calcitonin for prevention of postmenopausal bone loss.","volume":"1","author":"MacIntyre","year":"1988","journal-title":"Lancet"},{"key":"2019041122262581700_R52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2362.1991.tb01416.x","article-title":"Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.","volume":"21","author":"Marslew","year":"1991","journal-title":"Eur J Clin Invest"},{"key":"2019041122262581700_R53","first-page":"202","article-title":"Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.","volume":"79","author":"Marslew","year":"1992","journal-title":"Obstet Gynecol"},{"key":"2019041122262581700_R54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01352009","article-title":"A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women","volume":"53","author":"Meschia","year":"1993","journal-title":"Calcif Tissue Int."},{"key":"2019041122262581700_R55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(97)01110-9","article-title":"Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen\/progestin therapy: a 2-year prospective study.","volume":"27","author":"Mizunuma","year":"1997","journal-title":"Maturitas"},{"key":"2019041122262581700_R56","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/bmj.296.6630.1150","article-title":"Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study.","volume":"296","author":"Munk-Jensen","year":"1988","journal-title":"BMJ"},{"key":"2019041122262581700_R57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5122(94)90018-3","article-title":"Effects of percutaneous oestradiol versus oral oestrogens on bone density.","volume":"20","author":"Palacios","year":"1995","journal-title":"Maturitas"},{"key":"2019041122262581700_R58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5122(96)00999-1","article-title":"Prophylaxis of osteoporosis with calcium, estrogens and\/or eelcatonin: comparative longitudinal study of bone mass.","volume":"23","author":"Perez-Jaraiz","year":"1996","journal-title":"Maturitas"},{"key":"2019041122262581700_R59","first-page":"1389","article-title":"Effects of hormone therapy on none mineral density.","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"2019041122262581700_R60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-87-6-649","article-title":"Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.","volume":"87","author":"Recker","year":"1977","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1530\/acta.0.1230014","article-title":"Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.","volume":"123","author":"Resch","year":"1990","journal-title":"Acta Endocrinol"},{"key":"2019041122262581700_R62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM198701223160401","article-title":"Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.","volume":"316","author":"Riis","year":"1987","journal-title":"N Engl J Med"},{"key":"2019041122262581700_R63","first-page":"1","article-title":"Does calcium potentiate the effect of estrogen therapy on post-menopausal osteoporosis.","volume":"2","author":"Riis","year":"1987","journal-title":"Bone Miner"},{"key":"2019041122262581700_R64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-5122(88)90131-4","article-title":"Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.","volume":"10","author":"Riis","year":"1988","journal-title":"Maturitas"},{"key":"2019041122262581700_R65","first-page":"1904","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.","volume":"82","author":"Rosen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122262581700_R66","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"2019041122262581700_R67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2265.1993.tb02145.x","article-title":"Effect of long-term administration of progestogen on post-menopausal bone loss: result of a two year, controlled randomized study.","volume":"38","author":"Tremollieres","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122262581700_R68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9343(99)80102-8","article-title":"Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study.","volume":"99","author":"Wimalawansa","year":"1995","journal-title":"Am J Med"},{"key":"2019041122262581700_R69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9343(98)00029-1","article-title":"A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.","volume":"104","author":"Wimalawansa","year":"1998","journal-title":"Am J Med"},{"key":"2019041122262581700_R70","first-page":"3013","article-title":"Monoflurophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resoprtion in post-menopausal women: a randomized study.","volume":"84","author":"Alexandersen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122262581700_R71","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-131-12-199912210-00005","article-title":"Alendronate and estrogen-progestin in the long-term prevention of bone loss; four-year results from the Early Post-menopausal Intervention Cohort Study.","volume":"131","author":"Ravn","year":"1999","journal-title":"Ann Intern Med"},{"key":"2019041122262581700_R72","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone density predict occurrence of osteoporotic fractures.","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"2019041122262581700_R73","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials.","volume":"285","author":"Torgerson","year":"2001","journal-title":"JAMA"},{"key":"2019041122262581700_R74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/bmj.3.5879.515","article-title":"Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy.","volume":"3","author":"Aitken","year":"1993","journal-title":"BMJ"},{"key":"2019041122262581700_R75","first-page":"277","article-title":"Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.","volume":"53","author":"Nachtigall","year":"1979","journal-title":"Obstet Gynecol"},{"key":"2019041122262581700_R76","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1997.tb11981.x","article-title":"Effects on bone mass after eight years of hormonal replacement therapy.","volume":"104","author":"Eiken","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041122262581700_R77","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.160.14.2161","article-title":"Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism.","volume":"160","author":"Orr-Walker","year":"2000","journal-title":"Arch Intern Med"},{"key":"2019041122262581700_R78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer\u2019s Disease Cooperative Study.","volume":"283","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"key":"2019041122262581700_R79","first-page":"330","article-title":"A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss.","volume":"94","author":"Weiss","year":"1999","journal-title":"Obstet Gynecol"},{"key":"2019041122262581700_R80","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041122262581700_R81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5122(00)00158-4","article-title":"Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women; results of the Danish Osteoporosis Prevention Study.","volume":"36","author":"Mosekilde","year":"2000","journal-title":"Maturitas"},{"key":"2019041122262581700_R82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2474-2-7","article-title":"Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials.","volume":"2","author":"Torgerson","year":"2001","journal-title":"BMC Musculoskelet Disord"},{"key":"2019041122262581700_R83","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","article-title":"Prevention of spinal osteoporosis in oophorectomised women.","volume":"2","author":"Lindsay","year":"1980","journal-title":"Lancet"},{"key":"2019041122262581700_R84","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1210\/jcem.86.8.7703","article-title":"Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.","volume":"86","author":"Gallagher","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122262581700_R85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease and other considerations.","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annu Rev Public Health"},{"key":"2019041122262581700_R86","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke.","volume":"345","author":"Viscoli","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041122262581700_R87","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/hc2901.092200","article-title":"Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.","volume":"104","author":"Mosca","year":"2001","journal-title":"Circulation"},{"key":"2019041122262581700_R88","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"2019041122262581700_R89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women\u2019s Health Initiative clinical trial and observational study.","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"2019041122262581700_R90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5122(99)00109-7","article-title":"Commentary on the Women\u2019s Health Initiative.","volume":"34","author":"McGowan","year":"2000","journal-title":"Maturitas"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/23\/4\/529\/8861015\/edrv0529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:05:38Z","timestamp":1555088738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/23\/4\/529\/2433275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2002,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2001-5002","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}